Cocrystal Pharma, Inc. (COCP)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$13.1M
Cash & Equivalents
$2.3M
Quarterly Burn Rate
17 mo
Est. Cash Runway
$15M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT07198139 A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mou... PHASE2 Recruiting 40

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for COCP.

SEC EDGAR Filings

All SEC filings for Cocrystal Pharma, Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.